Todays Report: The Phillip Md Et Al Frost Acquires 5,600 Shares of Opko Health Inc. (OPK) Stock

The Phillip Md Et Al Frost Acquires 5,600 Shares of Opko Health Inc. (OPK) Stock

Opko Health Inc. (NYSE:OPK) CEO Phillip Md Et Al Frost purchased 5,600 shares of the company’s stock in a transaction that occurred on Wednesday, October 26th. The shares were acquired at an average cost of $9.27 per share, for a total transaction of $51,912.00. Following the completion of the transaction, the chief executive officer now directly owns 3,068,951 shares of the company’s stock, valued at approximately $28,449,175.77. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Phillip Md Et Al Frost also recently made the following trade(s): On Thursday, October 27th, Phillip Md Et Al Frost bought 10,000 shares of Opko Health stock. The stock was purchased at an average price of $9.36 per share, for a total transaction of $93,600.00. On Tuesday, October 25th, Phillip Md Et Al Frost bought 3,600 shares of Opko Health stock. The stock was purchased at an average price of $9.38 per share, for a total transaction of $33,768.00. On Monday, October 24th, Phillip Md Et Al Frost bought 1,800 shares of Opko Health stock. The stock was purchased at an average price of $9.50 per share, for a total transaction of $17,100.00. On Friday, October 21st, Phillip Md Et Al Frost bought 1,800 shares of Opko Health stock. The stock was purchased at an average price of $9.38 per share, for a total transaction of $16,884.00. On Thursday, October 20th, Phillip Md Et Al Frost bought 2,700 shares of Opko Health stock. The stock was purchased at an average price of $9.26 per share, for a total transaction of $25,002.00. On Wednesday, October 19th, Phillip Md Et Al Frost bought 14,700 shares of Opko Health stock. The stock was purchased at an average price of $9.26 per share, for a total transaction of $136,122.00. On Tuesday, October 18th, Phillip Md Et Al Frost bought 1,800 shares of Opko Health stock. The stock was purchased at an average price of $9.29 per share, for a total transaction of $16,722.00. On Monday, October 17th, Phillip Md Et Al Frost bought 3,600 shares of Opko Health stock. The stock was purchased at an average price of $9.34 per share, for a total transaction of $33,624.00. On Friday, October 14th, Phillip Md Et Al Frost bought 1,800 shares of Opko Health stock. The stock was purchased at an average price of $9.48 per share, for a total transaction of $17,064.00. On Thursday, October 13th, Phillip Md Et Al Frost bought 5,400 shares of Opko Health stock. The stock was purchased at an average price of $9.52 per share, for a total transaction of $51,408.00.

Shares of Opko Health Inc. (NYSE:OPK) opened at 9.46 on Monday. The company has a market cap of $5.21 billion and a P/E ratio of 39.58. The company’s 50-day moving average price is $10.07 and its 200 day moving average price is $9.98. Opko Health Inc. has a 52 week low of $7.12 and a 52 week high of $11.85.

Opko Health (NYSE:OPK) last issued its quarterly earnings data on Monday, August 8th. The company reported $0.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.03) by $0.05. The business had revenue of $357.10 million for the quarter, compared to analyst estimates of $324.11 million. The business’s quarterly revenue was up 742.2% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.09) EPS. On average, equities analysts forecast that Opko Health Inc. will post ($0.06) EPS for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in the stock. Janus Capital Management LLC increased its stake in Opko Health by 0.6% in the second quarter. Janus Capital Management LLC now owns 15,800 shares of the company’s stock valued at $148,000 after buying an additional 100 shares in the last quarter. Metropolitan Life Insurance Co. NY increased its stake in Opko Health by 1.2% in the second quarter. Metropolitan Life Insurance Co. NY now owns 22,945 shares of the company’s stock valued at $214,000 after buying an additional 261 shares in the last quarter. Gilman Hill Asset Management LLC increased its stake in Opko Health by 0.6% in the second quarter. Gilman Hill Asset Management LLC now owns 46,661 shares of the company’s stock valued at $436,000 after buying an additional 298 shares in the last quarter. Fisher Asset Management LLC increased its stake in Opko Health by 1.1% in the third quarter. Fisher Asset Management LLC now owns 38,229 shares of the company’s stock valued at $405,000 after buying an additional 403 shares in the last quarter. Finally, Capstone Asset Management Co. increased its stake in Opko Health by 3.3% in the third quarter. Capstone Asset Management Co. now owns 16,216 shares of the company’s stock valued at $172,000 after buying an additional 520 shares in the last quarter.

A number of research analysts have commented on the company. Zacks Investment Research upgraded Opko Health from a “sell” rating to a “hold” rating in a research note on Tuesday, October 25th. Oppenheimer Holdings Inc. reiterated a “hold” rating on shares of Opko Health in a research note on Monday, October 10th. Jefferies Group reiterated a “hold” rating and set a $10.00 price target on shares of Opko Health in a research note on Monday, October 10th. Finally, JPMorgan Chase & Co. set a $14.00 price target on Opko Health and gave the stock a “buy” rating in a research note on Tuesday, August 9th. Five equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $13.20.

Opko Health Company Profile

Related posts

Leave a Comment